BDBM161829 US9682976, 266::US9682976, 271

SMILES CC1(C)C[C@@H](C[C@@H]2CCCN12)Nc1nc(Nc2cccc(c2)-n2nnnc2SCCO)ncc1F

InChI Key InChIKey=DAJYCZLHWNYIPA-SJORKVTESA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 161829   

TargetInterleukin-2(Homo sapiens (Human))
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161829(US9682976, 266 | US9682976, 271)
Affinity DataEC50: <100nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-2(Homo sapiens (Human))
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM161829(US9682976, 266 | US9682976, 271)
Affinity DataEC50: <100nMAssay Description:Primary T cell stimulation and IL2 ELISA: Human primary T cells (100,000 cells per well) were pre-incubated with or without test compound in Yssel...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent